Facebook Tracking Image

National Comprehensive Cancer Network

About NCCN

NCCN Qualifies Lehigh Valley Health Network for Affiliate Research Project

The NCCN Oncology Research Program has qualified Lehigh Valley Health Network, Lehigh Valley, PA, as the latest addition to its Affiliate Research Project. Lehigh Valley Health Network is a community-based affiliate of Moffitt Cancer Center—one of the 23 NCCN Member Institutions.

FORT WASHINGTON, PA – The National Comprehensive Cancer Network® (NCCN®) Affiliate Research Project (ARP), developed by the NCCN Oncology Research Program (ORP), has qualified Lehigh Valley Health Network (LVHN), a member of the Moffitt Oncology Network (MON) of Moffitt Cancer Center in Tampa, Florida, as a community-based research affiliate for the project. Moffitt Cancer Center is one of the 23 NCCN Member Institutions.

Located in Lehigh Valley, Pennsylvania, LVHN is operating as an ARP site under the leadership of Suresh G. Nair, MD, Medical Director for Research and Principal Investigator, LVHN, and is the ninth community-based NCCN Member Institution affiliate to qualify for the NCCN ARP, increasing the scope of potential patients for the actively accruing ORP clinical trials. LVHN joins another Moffitt Cancer Center MON member, Norton Cancer Institute in Louisville, Kentucky, as an approved research site for NCCN ORP-supported trials.

Lehigh Valley Health Network will have access to new and innovative cancer drugs for patients in collaboration with NCCN Member Institutions, and Principal Investigators of NCCN-funded studies will have access to LVHN as an NCCN-qualified community site.

"NCCN is excited to collaborate with Lehigh Valley Health Network as the newest research affiliate to be approved for the NCCN ARP," said Diane Paul, MS, RN, Vice President, Oncology Research Program, NCCN. "Patients and investigators alike will benefit as we continue to add highly qualified, community-based research sites to the project."

The mission of the NCCN ARP is to improve patient outcomes and advance medical science through clinical research conducted collaboratively among the 23 NCCN Member Institutions and their community-based affiliate members.

In addition to LVHN and Norton Cancer Institute, affiliates within the project include AtlantiCare Cancer Care Institute, South Jersey Healthcare, and Virtua, affiliates of Fox Chase Cancer Center; Bozeman Deaconess Hospital, MultiCare Health System, and Wenatchee Valley Medical Center, affiliates of Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; and Medical Center of Central Georgia, affiliate of the University of Alabama at Birmingham Comprehensive Cancer Center.

The NCCN ORP is organized to obtain funding to support scientifically meritorious research projects at NCCN Member Institutions. Policies and standards for the program were set by the NCCN Investigator Steering Committee, a group comprised of senior research physicians appointed by each NCCN Member Institution. To date, the NCCN ORP has received more than $41 million in research grants from pharmaceutical and biotech companies to support investigator-initiated trials including, but not limited to, evaluation of innovative regimens, mechanism of action, and exploration of extended uses for specific agents.

About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of 30 leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, efficient, and accessible cancer care so patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. By defining and advancing high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers around the world.

The NCCN Member Institutions are:

  • Abramson Cancer Center at the University of Pennsylvania
  • Fred & Pamela Buffett Cancer Center
  • Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
  • City of Hope National Medical Center
  • Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center
  • Duke Cancer Institute
  • Fox Chase Cancer Center
  • Huntsman Cancer Institute at the University of Utah
  • Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
  • The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • Mayo Clinic Cancer Center
  • Memorial Sloan Kettering Cancer Center
  • Moffitt Cancer Center
  • The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
  • O'Neal Comprehensive Cancer Center at UAB
  • Roswell Park Comprehensive Cancer Center
  • Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
  • St. Jude Children's Research Hospital/The University of Tennessee Health Science Center
  • Stanford Cancer Institute
  • UC San Diego Moores Cancer Center
  • UCLA Jonsson Comprehensive Cancer Center
  • UCSF Helen Diller Family Comprehensive Cancer Center
  • University of Colorado Cancer Center
  • University of Michigan Rogel Cancer Center
  • The University of Texas MD Anderson Cancer Center
  • University of Wisconsin Carbone Cancer Center
  • UT Southwestern Simmons Comprehensive Cancer Center
  • Vanderbilt-Ingram Cancer Center
  • Yale Cancer Center/Smilow Cancer Hospital